{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:37:09Z","timestamp":1789040229502,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-072073"],"award-info":[{"award-number":["INV-072073"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Federal Government | DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2026574"],"award-info":[{"award-number":["APP2026574"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-025-00300-9","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:03:21Z","timestamp":1759151001000},"page":"2847-2849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Better late than never: defining the ideal vaccine that targets pre-erythrocytic malaria infection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5629-435X","authenticated-orcid":false,"given":"Grace M","family":"Rochfort Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-352X","authenticated-orcid":false,"given":"Jake","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"300_CR1","doi-asserted-by":"publisher","unstructured":"Borrmann S, Sulyok Z, M\u00fcller K, Fendel R, Sulyok M, Friesen J, Lalremruata A, Sandri TL, Nguyen TT, Calle CL et al (2025) Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil. EMBO Mol Med. https:\/\/doi.org\/10.1038\/s44321-025-00301-8","DOI":"10.1038\/s44321-025-00301-8"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.chom.2011.05.008","volume":"9","author":"NS Butler","year":"2011","unstructured":"Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT (2011) Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9:451\u2013462","journal-title":"Cell Host Microbe"},{"key":"300_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101579","volume":"52","author":"D Coulibaly","year":"2022","unstructured":"Coulibaly D, Kone AK, Traore K, Niangaly A, Kouriba B, Arama C, Zeguime A, Dolo A, Lyke KE, Plowe CV et al (2022) PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: a randomized, controlled phase 1 trial. EClinicalMedicine 52:101579","journal-title":"EClinicalMedicine"},{"key":"300_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S1473-3099(24)00360-8","volume":"24","author":"H Diawara","year":"2024","unstructured":"Diawara H, Healy SA, Mwakingwe-Omari A, Issiaka D, Diallo A, Traore S, Soumbounou IH, Gaoussou S, Zaidi I, Mahamar A et al (2024) Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis 24:1366\u20131382","journal-title":"Lancet Infect Dis"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","volume":"391","author":"OAC Lamers","year":"2024","unstructured":"Lamers OAC, Franke-Fayard BMD, Koopman JPR, Roozen GVT, Janse JJ, Chevalley-Maurel SC, Geurten FJA, de Bes-Roeleveld HM, Iliopoulou E, Colstrup E et al (2024) Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. N Engl J Med 391:1913\u20131923","journal-title":"N Engl J Med"},{"key":"300_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordmuller","year":"2017","unstructured":"Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ et al (2017) Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542:445\u2013449","journal-title":"Nature"},{"key":"300_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-021-01470-y","volume":"27","author":"M Oneko","year":"2021","unstructured":"Oneko M, Steinhardt LC, Yego R, Wiegand RE, Swanson PA, Kc N, Akach D, Sang T, Gutman JR, Nzuu EL et al (2021) Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial. Nat Med 27:1636\u20131645","journal-title":"Nat Med"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/14760584.2023.2245890","volume":"22","author":"TL Richie","year":"2023","unstructured":"Richie TL, Church LWP, Murshedkar T, Billingsley PF, James ER, Chen MC, Abebe Y, K CN, Chakravarty S, Dolberg D et al (2023) Sporozoite immunization: innovative translational science to support the fight against malaria. Expert Rev Vaccines 22:964\u20131007","journal-title":"Expert Rev Vaccines"},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T et al (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468\u2013477","journal-title":"N Engl J Med"},{"key":"300_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj3776","volume":"14","author":"SB Sirima","year":"2022","unstructured":"Sirima SB, Ou\u00e9draogo A, Tiono AB, Kabor\u00e9 JM, Bougouma EC, Ouattara MS, Kargougou D, Diarra A, Henry N, Ou\u00e9draogo IN et al (2022) A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria. Sci Transl Med 14:eabj3776","journal-title":"Sci Transl Med"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/iai.58.9.2834-2839.1990","volume":"58","author":"A Suhrbier","year":"1990","unstructured":"Suhrbier A, Winger LA, Castellano E, Sinden RE (1990) Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect Immun 58:2834\u20132839","journal-title":"Infect Immun"},{"key":"300_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101073","volume":"6","author":"P Venkatesan","year":"2025","unstructured":"Venkatesan P (2025) WHO World Malaria Report 2024. Lancet Microbe 6:101073","journal-title":"Lancet Microbe"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00300-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00300-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00300-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:06Z","timestamp":1779065046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00300-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,10]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00300-9","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}